Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.14 +0.02 (+0.20%)
At close: Aug 20, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMII) EBT (2025)

Drugs Made In America Acquisition (DMII) posted quarterly EBT of $4.6 million for Q4 2025, up 10041.88% quarter-over-quarter from -$46158.0 in Q3 2025.

Drugs Made In America Acquisition (DMII) EBT (2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has reported EBT for 1 consecutive years, with $4.6 million the latest figure, recorded in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 2.11 Mn
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 1.95 Mn
3 Drugs Made In America Acquisition 506.00 Mn 506.00 Mn - 4.40 Mn
4 Cantor Equity Partners IV 467.55 Mn 467.55 Mn - 3.92 Mn
5 New Providence Acquisition Corp. III 401.18 Mn 401.18 Mn - 2.24 Mn
6 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 290,121.00
7 Aldel Financial 397.49 Mn 397.49 Mn - 2.11 Mn
8 Bold Eagle Acquisition 391.94 Mn 391.94 Mn - 1.01 Mn
9 Pioneer Acquisition I 390.89 Mn 653.32 Mn - -177,258.00
10 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 2.65 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 4.59 Mn
Sep 30, 2025 -46,158.00